Current
First year
Haleigh Gilliland
PhD Program: Microbiology & Molecular Biology
Lab: Olive
Research: Dissecting host mechanisms that alter virulence activation and drug pathways in Mycobacterial species.
Jacob Howe
PhD Program: Neuroscience
Lab: Sortwell
Research: Inhibition of NLRP3 inflammasome activation as a neuroprotective strategy against synucleinopathy in Parkinson's Disease.
Jariel Ramirez-Virella
PhD Program: Neuroscience
Lab: Leinninger
Research: Endogenous and pharmacological activation of Neurotensin Receptor-1 to modulate body weight.
Skye Russell
PhD Program: Chemistry
Lab: Swain
Research: Development and application of electrochemical biosensors and chemical sensors for studying inhibitory neuromuscular signaling in the gastrointestinal tract.
Second year
Laura Chambers
PhD program: Pharmacology and Toxicology
Lab: Dorrance
Research: The role of mineralocorticoid receptor activation in the development of vascular cognitive impairment and dementia.
Olivia Favor
PhD program: Pharmacology and Toxicology
Lab: Lee
Research: Mechanisms by which epoxy fatty acids reduce inflammation in autoimmune systemic lupus erythematosus
Rebecca Mueller
PhD program: Neuroscience
Lab: Kanaan
Research: The potential anti-aggregation effects of tricyclic antidepressants on the protein tau in the context of Alzheimer's disease.
Sophia Staerz
PhD program: Chemistry
Lab: Tepe
Research: Development of small molecule proteasome activators as a new treatment pathway for neurodegenerative diseases such as Parkinson and Alzheimers.
Previously supported
Kevin Chen – Chemical Engineering and Materials Science
Shelby DeChow – Microbiology and Molecular Genetics
Lucas Demey - Microbiology and Molecular Genetics
Bronson Gregory - Physiology
Taylor Fiolek - Chemistry
Patricia Perez-Bonilla – Neuroscience (funded by an NIH F31)
Chauncey Splichal - Chemical Engineering and Materials Science
Anna Stoll – Pharmacology and Toxicology